Prostate cancer, Secondary cancers
Results
Phase 1
This trial looked at idasanutlin for prostate cancer that was no longer responding to hormone therapy and had spread to another part of the body.
The trial was supported by Cancer Research UK. People could join between 2014 and 2017. The team presented the results at a conference in 2018.
Idasanutlin is pronounced eye-dah-san-ut-lin.
Recruitment start: 31 March 2014
Recruitment end: 3 July 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Rob Jones
Cancer Research UK
NHS Greater Glasgow and Clyde
NIHR Clinical Research Network: Cancer
Roche
University of Glasgow
This is Cancer Research UK trial number CRUKE/12/032.
Last reviewed: 24 Feb 2026
CRUK internal database number: 10085
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
